Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the role of KRAS mutations in epidermal growth factor receptor–targeted therapies for patients with colorectal cancer
- Describe recent clinical trial results related to adjuvant chemotherapy in colorectal cancer
- Explain the efficacy of dual antibody therapy in the treatment of refractory and frontline metastatic colorectal cancer
- Review the role of positron emission tomography in patient selection for surgical resection of metastatic colorectal cancer
CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.